SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017285
Filing Date
2022-11-10
Accepted
2022-11-10 07:15:34
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20220930x10q.htm   iXBRL 10-Q 1916027
2 EX-10.1 pasg-20220930xex10d1.htm EX-10.1 100537
3 EX-31.1 pasg-20220930xex31d1.htm EX-31.1 16637
4 EX-31.2 pasg-20220930xex31d2.htm EX-31.2 16159
5 EX-32.1 pasg-20220930xex32d1.htm EX-32.1 6319
6 EX-32.2 pasg-20220930xex32d2.htm EX-32.2 6380
7 GRAPHIC pasg-20220930x10q001.jpg GRAPHIC 71069
  Complete submission text file 0001558370-22-017285.txt   6981400

Data Files

Seq Description Document Type Size
8 EX-101.SCH pasg-20220930.xsd EX-101.SCH 43104
9 EX-101.CAL pasg-20220930_cal.xml EX-101.CAL 43887
10 EX-101.DEF pasg-20220930_def.xml EX-101.DEF 136202
11 EX-101.LAB pasg-20220930_lab.xml EX-101.LAB 399355
12 EX-101.PRE pasg-20220930_pre.xml EX-101.PRE 275018
55 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20220930x10q_htm.xml XML 1156446
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 221374919
SIC: 2836 Biological Products, (No Diagnostic Substances)